Doubling the dose of the anticlotting drug Plavix does not reduce heart attacks or deaths in certain high-risk people, researchers report.
Read more here:
New Plavix Findings Fuel Debate on Platelet Testing
You must be logged in to post a comment.
Posted by
on November 17, 2010. Filed under